Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: Therapeutic potential of MSCs and MSC-derived extracellular vesicles in immune thrombocytopenia

Fig. 1

Phenotype and function of MSCs in healthy individuals and ITP patients. MSCs were involved in platelet production by interacting with immune cells, including inhibition of mDC maturation; regulation of the ratio of T lymphocyte subsets; inhibition of lymphocyte proliferation; inhibition of antibody release from B cells; and promotion of platelet production from megakaryocyte maturation. The function of ITP-MSCs was impaired, mainly by: increased G0/G1 cells with restricted proliferation; increased apoptosis; decreased concentration of CXCL12, which may contribute to reduced ability of megakaryocytes to migrate from the bone marrow sinus to the blood sinus; increased release of pro-inflammatory cytokines; ⑩ broad and flattened appearance; ⑪ increased apoptosis of MSCs due to complement deposition. Ps: copyright permission is not applicable

Back to article page